GA
About
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 3 investors are based in Mechelen-bovelingen, Limburg, Belgium.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Mechelen-bovelingen, Belgium
Contact Information
Find more investors like Galapagos
Search Investors